Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-dnli
/
Denali Therapeutics Inc
DNLI
Add to Watchlist
25.720
USD
-0.170
-0.66%
Close 06/30, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/01, 09:30 (ET)
4.08B
Market Cap
Loss
P/E TTM
Denali Therapeutics Inc
25.720
-0.170
-0.66%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Baillie Gifford & Co.
7.60%
BlackRock Institutional Trust Company, N.A.
6.56%
T. Rowe Price Investment Management, Inc.
4.57%
Biogen Inc
4.51%
Temasek Holdings Pte. Ltd.
4.42%
Other
72.34%
Shareholders
Shareholders
Proportion
Baillie Gifford & Co.
7.60%
BlackRock Institutional Trust Company, N.A.
6.56%
T. Rowe Price Investment Management, Inc.
4.57%
Biogen Inc
4.51%
Temasek Holdings Pte. Ltd.
4.42%
Other
72.34%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.46%
Investment Advisor/Hedge Fund
21.59%
Hedge Fund
14.03%
Sovereign Wealth Fund
7.64%
Individual Investor
4.62%
Corporation
4.51%
Research Firm
2.29%
Bank and Trust
1.11%
Private Equity
0.63%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
555
158.73M
100.01%
+922.46K
2025Q4
520
148.33M
104.72%
+27.93K
2025Q3
534
148.30M
106.07%
+2.76M
2025Q2
533
144.90M
104.92%
+4.11M
2025Q1
521
140.91M
100.82%
-5.51M
2024Q4
508
135.26M
104.03%
-2.70M
2024Q3
500
139.34M
103.43%
+2.39M
2024Q2
486
129.82M
93.98%
+2.48M
2024Q1
475
127.09M
84.98%
+6.07M
2023Q4
485
116.85M
84.85%
+2.16M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Baillie Gifford & Co.
12.31M
7.76%
+719.30K
+6.21%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.41M
6.56%
+283.36K
+2.80%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
7.25M
4.57%
+1.62M
+28.65%
Dec 31, 2025
Biogen Inc
7.16M
4.51%
-5.60M
-43.89%
Oct 30, 2024
Temasek Holdings Pte. Ltd.
7.01M
4.42%
+1.66M
+30.94%
Dec 31, 2025
State Street Investment Management (US)
6.26M
3.95%
+799.11K
+14.62%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
5.12M
3.23%
+1.17M
+29.70%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.79M
3.02%
-223.13K
-4.45%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
4.13%
Global X Guru Index ETF
1.33%
ALPS Medical Breakthroughs ETF
0.98%
Virtus LifeSci Biotech Clinical Trials ETF
0.74%
State Street SPDR S&P Biotech ETF
0.73%
Direxion Daily S&P Biotech Bull 3X Shares
0.45%
Global X Aging Population ETF
0.38%
ProShares Ultra Nasdaq Biotechnology
0.35%
iShares Health Innovation Active ETF
0.35%
Invesco Nasdaq Biotechnology ETF
0.23%
View more
iShares Neuroscience and Healthcare ETF
Proportion
4.13%
Global X Guru Index ETF
Proportion
1.33%
ALPS Medical Breakthroughs ETF
Proportion
0.98%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0.74%
State Street SPDR S&P Biotech ETF
Proportion
0.73%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.45%
Global X Aging Population ETF
Proportion
0.38%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.35%
iShares Health Innovation Active ETF
Proportion
0.35%
Invesco Nasdaq Biotechnology ETF
Proportion
0.23%